Abstract PO1-06-12: Phase II Study of Sitravatinib Plus Tislelizumab with or Without Nab-Paclitaxel in Patients with Locally Recurrent or Metastatic Triple Negative Breast Cancer
CANCER RESEARCH（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要